135 related articles for article (PubMed ID: 1740540)
1. Evaluation of quinapril on regional blood flow and cardiac function in patients with congestive heart failure.
Munger MA; Chance M; Nair R; Prescott AW; Nara AR; Simonson MS; Green JA; Posvar EL
J Clin Pharmacol; 1992 Jan; 32(1):70-6. PubMed ID: 1740540
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic effects of quinapril, a novel angiotensin-converting enzyme inhibitor.
Gupta RK; Kjeldsen SE; Krause L; Kneisley J; Posvar E; Weder AB; Julius S
Clin Pharmacol Ther; 1990 Jul; 48(1):41-9. PubMed ID: 2196144
[TBL] [Abstract][Full Text] [Related]
3. Regression of left ventricular hypertrophy and improvement of renal hemodynamics in hypertensive patients treated with quinapril.
De Caprio L; De Rosa ML; Di Palma A; Lirato C; Caccese P; Sestito M; Lastoria S; Cicatiello AM; Rengo F
Cardiovasc Drugs Ther; 1994 Oct; 8(5):735-40. PubMed ID: 7873470
[TBL] [Abstract][Full Text] [Related]
4. Determinants of the renal response to ACE inhibition in patients with congestive heart failure.
Gottlieb SS; Robinson S; Weir MR; Fisher ML; Krichten CM
Am Heart J; 1992 Jul; 124(1):131-6. PubMed ID: 1615796
[TBL] [Abstract][Full Text] [Related]
5. [Advantages of quinapril therapy in patients with arterial hypertension and functional class III chronic heart failure with preserved left ventricular ejection fraction].
Kanorskiĭ SG; Tregubov VG; Pokrovskiĭ VM
Kardiologiia; 2012; 52(4):31-7. PubMed ID: 22839514
[TBL] [Abstract][Full Text] [Related]
6. Effects of ANG-converting enzyme and alpha 1-adrenoceptor inhibition on intrarenal hemodynamics in SHR.
Numabe A; Komatsu K; Frohlich ED
Am J Physiol; 1994 May; 266(5 Pt 2):R1437-42. PubMed ID: 8203617
[TBL] [Abstract][Full Text] [Related]
7. The effect of angiotensin converting enzyme inhibition on myocardial function and blood pressure after coronary artery bypass surgery--a randomised study.
Webb CM; Underwood R; Anagnostopoulos C; Bennett JG; Pepper J; Lincoln C; Collins P
Eur J Cardiothorac Surg; 1998 Jan; 13(1):42-8. PubMed ID: 9504729
[TBL] [Abstract][Full Text] [Related]
8. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
Plosker GL; Sorkin EM
Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
[TBL] [Abstract][Full Text] [Related]
9. Dose-related effects of ACE inhibition in man: quinapril in patients with moderate congestive heart failure. The Study Group on Neurohormonal Regulation in Congestive Heart Failure: Lausanne, Switzerland; Berlin, Düsseldorf, Munich, Germany.
Nussberger J; Fleck E; Bahrmann H; Delius W; Schultheiss HP; Brunner HR
Eur Heart J; 1994 Dec; 15 Suppl D():113-22. PubMed ID: 7713100
[TBL] [Abstract][Full Text] [Related]
10. Quinapril in patients with congestive heart failure: controlled trial versus captopril.
Acanfora D; Furgi G; Trojano L; Picone C; Iannuzzi GL; Rossi M; Papa A; Rengo C; Rengo F
Am J Ther; 1997; 4(5-6):181-8. PubMed ID: 10423609
[TBL] [Abstract][Full Text] [Related]
11. Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow.
Leier CV; Patrick TJ; Hermiller J; Pacht KD; Huss P; Magorien RD; Unverferth DV
Am Heart J; 1984 Dec; 108(6):1461-8. PubMed ID: 6507242
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic and morphological effects of quinapril during genetic hypertension development.
Richer C; Mulder P; Fornes P; Richard V; Camilleri JP; Giudicelli JF
J Cardiovasc Pharmacol; 1991 Oct; 18(4):631-42. PubMed ID: 1724542
[TBL] [Abstract][Full Text] [Related]
13. Changes in pulmonary hemodynamics predict benefits in exercise capacity after ACE inhibition in patients with mild to moderate congestive heart failure.
Pelliccia F; Borghi A; Ruggeri A; Cianfrocca C; Morgagni GL; Bugiardini R
Clin Cardiol; 1993 Aug; 16(8):607-12. PubMed ID: 8370193
[TBL] [Abstract][Full Text] [Related]
14. ACE inhibition prevents and reverses L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats.
Ono H; Ono Y; Frohlich ED
Hypertension; 1996 Feb; 27(2):176-83. PubMed ID: 8567038
[TBL] [Abstract][Full Text] [Related]
15. Renal and systemic hemodynamic effects of ibopamine in patients with mild to moderate congestive heart failure.
Lieverse AG; van Veldhuisen DJ; Smit AJ; Zijlstra JG; Meijer S; Reitsma WD; Lie KI; Girbes AR
J Cardiovasc Pharmacol; 1995 Mar; 25(3):361-7. PubMed ID: 7769799
[TBL] [Abstract][Full Text] [Related]
16. Effect of quinapril on blood pressure and heart rate in congestive heart failure.
Townend JN; West JN; Davies MK; Littler WA
Am J Cardiol; 1992 Jun; 69(19):1587-90. PubMed ID: 1598874
[TBL] [Abstract][Full Text] [Related]
17. Relation of functional improvement in congestive heart failure after quinapril therapy to peripheral limitation.
Jondeau G; Dib JC; Dubourg O; Bourdarias JP
Am J Cardiol; 1997 Mar; 79(5):635-8. PubMed ID: 9068523
[TBL] [Abstract][Full Text] [Related]
18. The hemodynamics effects of ACE inhibitors in the treatment of congestive heart failure.
Nieminen MS; Kupari M
J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S36-40. PubMed ID: 1691405
[TBL] [Abstract][Full Text] [Related]
19. The acute haemodynamic effects of quinapril, a new non-sulfhydryl angiotensin converting enzyme inhibitor, in patients with severe congestive cardiac failure.
Holt P; Najm J; Sowton E
Eur J Clin Pharmacol; 1986; 31(1):9-14. PubMed ID: 3023100
[TBL] [Abstract][Full Text] [Related]
20. Quinapril in chronic heart failure.
Northridge DB; Dargie HJ
Am J Hypertens; 1990 Nov; 3(11):283S-287S. PubMed ID: 2261147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
